Laparoscopic/Robotic-assisted Hysteropexy Versus Vaginal Hysterectomy for the Treatment of Uterovaginal Prolapse
- Conditions
- Uterovaginal ProlapseHysteropexy
- Interventions
- Procedure: patient who undergo laparoscopic/robotic-assisted hysteropexyProcedure: patient who undergo vaginal hysterectomy
- Registration Number
- NCT02877407
- Lead Sponsor
- Seoul National University Hospital
- Brief Summary
* objective: aimed to compare laparoscopic/robot-assisted hysteropexy with vaginal hysterectomy for uterine prolapse
* prospective randomized clinical trial
* patient
1. 60yrs or more women and
2. POP-Q stage II with symptom or POP-Q III, IV regardless of symptom
* number of patient: 146
* randomize: laparoscopic/robot-assisted hysteropexy vs. hysterectomy
* follow up: postoperative 1 year
* primary endpoint: recurrence rate
1. recurrence of uterovaginal prolapse POP-Q stage II-IV
2. recurrence of associated symptom
* secondary endpoint
1. postoperative 1 year QOL, degree of satisfaction evaluation
2. operative time, estimated blood loss
3. hospitalization period, postoperative pain, return to normal activity
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- Female
- Target Recruitment
- 146
- POP-Q stage II with symptom or POP-Q III, IV regardless of symptom
- abnormal uterine bleeding
- significantly enlarged fibroid uterus
- postmenopausal uterine bleeding
- endometrial pathology
- on tamexifen
- concomitant medical problems precluding general anesthesia or surgery
- damaged agreement ability
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description laparoscopic/robotic-assisted hysteropexy patient who undergo laparoscopic/robotic-assisted hysteropexy patient who undergo laparoscopic/robotic-assisted hysteropexy vaginal hysterectomy patient who undergo vaginal hysterectomy patient who undergo vaginal hysterectomy
- Primary Outcome Measures
Name Time Method recurrence rate (%) postoperative 1 year recurrence rate(%) of uterovaginal prolapse POP-Q stage II-IV in postoperative 1 year
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Seoul National Univesity Bundang Hospital
🇰🇷Seongnam-si, Kyeonggi-do, Korea, Republic of